Efficacy and Safety of Tezepelumab in Participants With Severe Chronic Rhinosinusitis With Nasal Polyposis
Clinical trial NCT04851964 · COMPLETED
Trial details
- NCT number
- NCT04851964
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-22
- Primary completion
- 2024-09-23
- Enrollment
- 416
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.